|Last name||de Baar|
Corporate investor, Seed funding, Venture capital, Biotech, Drug Delivery, Drug Discovery, Immunology, Medicine, Therapeutics, Business strategy, IP & Licensing, Startups, microbiology, cardiology, endocrinology / diabetes, infectious diseases, ophthalmology / optometry, respiratory medicine, antibodies, nucleic acid drugs, peptides, proteins, small molecules, vaccines
Michel is a business development and licensing professional with experience in all steps of business transaction processes within the global pharmaceutical and biotechnology industry. He uses and has used his expertise to help companies and institutes to partner or acquire their products and projects as consultant and employee. As an (ex)-entrepreneur he has experience with fund raising for startup companies, including his own biotech company. His key attribute is to bridge science and business.
Michel is currently an Executive Director in business development and licensing for MSD. He is responsible for all European business development transactions around assets within the therapeutic areas of Infectious Diseases, Vaccines, Cardiovascular-, Metabolic-, Immunology- & Inflammatory Diseases.
MSD has a corporate ventures fund that strategically invests in prior-to-clinical opportunities.
Michel is a member of the Licensing Executives Society (LES) .